Skip to main content

Table 1 clinical and demographic results of the patients in groups I and II

From: Role of circulating miR 194-5p, miR 106b, and miR 146a as potential biomarkers for epilepsy: a case-control study

 

Group I

Group II

p value

Mean ± SD

Mean ± SD

Age (yrs.)

27.47 ± 7.25

35.27 ± 9.72

0.015*

Age of onset (yrs.)

16.53 ± 5.67

17.47 ± 9.20

0.870

BMI

23.96 ± 2.13

23.36 ± 2.31

0.412

Disease duration (yrs.)

10.93 ± 7.07

17.80 ± 11.63

0.089

Seizure frequency

28.64 ± 3.21

13.19 ± 25.49

0.724

Positive family history of epilepsy,N(%)

4 (26.7%)

4 (26.7%)

0.356

  1. BMI body mass index, N number, SD standard deviation, yrs. years
  2. *Significant p ˂ 0.05